Filing Flows › Novartis AG (NVS) › Q3 2026
Novartis AG (NVS) Q3 2026 earnings results (third quarter 2026)
6-K filed Oct 27, 2026
Novartis AG (NVS) reported revenue of $14.5B for the third quarter 2026 (Q3 2026), +4% from a year earlier. Operating margin was 12.7%, net earnings $1.2B (8.2% of revenue).
Novartis AG, Q3 2026: revenue $14.5B (+4% year over year), operating margin 12.7%, net earnings $1.2B, operating cash flow $5.5B. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $14.5B | — | +4% |
| Operating profit | $1.8B | — | -59% |
| Net earnings | $1.2B | — | -70% |
| Operating cash flow | $5.5B | — | -16% |
What changed
Revenue was $14.5B in Q3 2026, up 4% year over year.
Operating profit was $1.8B, a 12.7% margin (down 19.7 points year over year). Operating profit fell $2.7B even though revenue rose $0.61B versus a year earlier, so costs grew faster than sales. Total costs grew 35% against revenue growth of 4%. Net earnings were $1.2B, down 70% year over year. The effective tax rate was 0.0%.
Operating cash flow was $5.5B (down 16% year over year), 460% of net earnings. Working capital and other items added $4.3B.
Questions
What was Novartis AG's revenue in the third quarter 2026?
Novartis AG (NVS) reported revenue of $14.5B for the third quarter 2026 (Q3 2026), +4% from a year earlier.
Was Novartis AG profitable in the third quarter 2026?
Operating profit was $1.8B (12.7% of revenue) and net earnings $1.2B.
Source: Novartis AG 6-K on SEC EDGAR.